Results 151 to 160 of about 47,637 (238)

Comprehensive analysis of m⁶A methylomes in idiopathic pulmonary arterial hypertension. [PDF]

Epigenetics, 2023
Huang T, Zeng Y, Yang Y, Fan H, Deng Y, Chen W, Liu J, Yang F, Li W, Xiao Y.   +9 more
europepmc   +1 more source

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension

American Journal of Respiratory and Critical Care Medicine, 2022
Tracy M. Frech, Eric D. Austin
openaire   +2 more sources

[Treatment of idiopathic pulmonary arterial hypertension].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2011
In the past 5-10 years, drug treatment of idiopathic pulmonary arterial hypertension has evolved considerably. Experience and results from use of such updated treatment in Norway has not been reported.32 patients newly diagnosed with idiopathic pulmonary arterial hypertension, were consecutively assessed with respect to hemodynamics and physical ...
Arne K, Andreassen, Einar, Gude, Ole Geir, Solberg, Thor, Ueland   +3 more
openaire   +1 more source

Lifesaving Compassionate-Use of Sotatercept in a 12-Year-old With Idiopathic Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Pelczar-Płachta W, Surmacz R, Bobkowski W.   +2 more
europepmc   +1 more source

Coronary pathophysiology in idiopathic pulmonary arterial hypertension. [PDF]

JCI Insight
Boland E, Freeman MG, Corcoran DS, Ford TJ, Hennigan B, Collison D, Llucià-Valldeperas A, de Man FS, Balachandran KP, Johnson M, Church C, Berry C.   +11 more
europepmc   +1 more source

Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertension. [PDF]

NPJ Cardiovasc Health
Delgado-SanMartin JA, Keles M, Errington N, Schuetz N, Johnson A, Gupta V, Hershman S, Toshner M, Wilkins MR, Kiely DG, Thompson R, Ashley E, Wang D, Lawrie A.   +13 more
europepmc   +1 more source

Initial triple combination therapy including sotatercept in a patient with severe idiopathic pulmonary arterial hypertension: a case report. [PDF]

ERJ Open Res
Park DH, Kamp JC, Seeliger B, Hoeper MM, Olsson KM.   +4 more
europepmc   +1 more source

Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension. [PDF]

Clin Respir J
Li M, Jin Q, Pan W, Tian D, Wang P, Chen D, Zhang Y, Chen S, Zhou D, Guan L, Ge J.   +10 more
europepmc   +1 more source

A Case of IgG4-Related Disease Developing During Long-Term High-Dose Intravenous Epoprostenol Therapy in a Patient With Idiopathic Pulmonary Arterial Hypertension. [PDF]

Pulm Circ
Inao T, Nakayama K, Yasui S, Shite N, Shiraki E, Ohbayashi C, Otsuka K, Onishi H, Ohta S, Iwahashi M.   +9 more
europepmc   +1 more source

Multi-omics integration study of vascular smooth muscle cell phenotypic conversion identified novel biomarkers in idiopathic pulmonary arterial hypertension. [PDF]

Respir Res
Wu R, Wang K, Fan M, Jia R, Ma Y, Yuan C, Yu M, Guo M, Jiang T, Wang Y, Li Y, Li P, Liu Y, Gong Y, Cheng Z.   +14 more
europepmc   +1 more source